Pro Re Nata Intravitreal Bevacizumab for the Treatment of Idiopathic Choroidal Neovascular Membrane

  • Seminars in Ophthalmology, November 2014, Taylor & Francis
  • DOI: 10.3109/08820538.2014.962172
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr KUMAR SAURABH

In partnership with: